FindTrial
Sign In

To evaluate the utility of INR to albumin ratio as a predictor of severity in chronic liver disease patients

INR to albumin ratio as a predictor of severity in chronic liver disease - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/06/069001
Enrollment
85
Registered
2024-06-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K768- Other specified diseases of liver

Interventions

Intervention1: nil: nil Control Intervention1: nil: nil

Sponsors

Kasturba Medical College Manipal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosis by ultrasonography (coarse echotexture, increased echogenicity, and nodularity of liver surface)

Exclusion criteria

Exclusion criteria: 1) Participants on anticoagulant therapy that could influence INR 2) Chronic kidney disease, which could affect albumin levels 3) Participants with acute liver disease and fulminant hepatic failure

Design outcomes

Primary

MeasureTime frame
The INR to albumin ratio and its association with patients with chronic liver disease and its severity will be calculated and whether a significant association is found with child Turcotte Pugh and Meld-Na will be calculated.Timepoint: 3 years—

Secondary

MeasureTime frame
To evaluate the correlation between INR to albumin ratio with child Turcotte Pugh score and MELD-Na scoreTimepoint: 3 years—

Countries

India

Contacts

Public ContactDr Weena Stanley

Kasturba Medical College , Manipal

weena.stanley@manipal.edu9844111974

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026